Association between sézary t cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma

Annals of the New York Academy of Sciences

Volumn 941, Issue , 2001, Pages 69-85

  Todd Abrams, J ^a,b   Balin, Brian J ^b   Vonderheid, Eric C ^c  

^a Meniscus Limited   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chlamydia pneumoniae; S zary T cell activating factor

Indexed keywords

BACTERIUM ANTIBODY; CELL DNA; CHLAMYDIAL ANTIBODY; INTERLEUKIN 2; PSORALEN; RNA; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; BACTERIAL GROWTH; CANCER RADIOTHERAPY; CELL ACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; CYTOGENETICS; GENE ISOLATION; GENETIC CODE; HOST CELL; HUMAN; KERATINOCYTE; LYMPHOCYTE CLONE; POLYMERASE CHAIN REACTION; SEZARY CELL; SEZARY SYNDROME; SKIN LYMPHOMA; T CELL LYMPHOMA; TUMOR CELL LINE; ULTRAVIOLET A RADIATION;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; EUKARYOTA; RICKETTSIALES;

EID: 0034814657     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03712.x     Document Type: Conference Paper

References (33)

1. Infectious causation of disease: An evolutionary perspective
2. Chlamydia pneumoniae and cardiovascular disease: An evolutionary perspective on infectious causation and antibiotic treatment
3. Are all diseases infectious?
4. Th2 cytokine: Profile in cutaneous T-cell lymphoma
5. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas
6. The immunopathogenesis of cutaneous T-cell lymphoma
7. Lymphocyte activation in cutaneous T-cell lymphoma
8. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2
9. Expression of class II major histocompatibility antigens by keratinocytes in cutaneous T cell lymphoma
10. Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome
11. The control of T cell responses by dendritic cell subsets
12. Mycosis fungoides - A disease of antigen persistence
13. A clonal CD4-positive T-cell line established from the blood of a patient with Sézary syndrome
14. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome
15. The most common chromosome change in 86 chronic B cell or T cell tumors: A 14q32 translocation
16. + T cell responses common to Plasmodium falciparum and recall antigens
17. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens
18. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
19. Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein
20. Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma
21. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients
22. The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas
23. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
24. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
25. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: A possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae
26. T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens
27. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
28. Chlamydia pneumoniae present in the human synovium are viable and metabolically active
29. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
30. The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy
31. Characterization of Chlamydia pneumoniae antigens using human T cell clones
32. Cell mediated immunity to Chlamydia pneumoniae
33. Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10